IL6 and hepatocellular carcinoma: Taken together, our results suggested that deletion of IL6 promoted HCC development and increased tumor burden, NK cells, TNFα and IFNγ were significantly reduced in tumors of DDB1F/F, Alb-Cre+/−, IL6−/− mouse.